Related references
Note: Only part of the references are listed.CD33 mRNA Has Elevated Expression Levels in the Leukocytes of Peripheral Blood in Patients with Late-Onset Alzheimer's Disease
Fatemeh Heidari et al.
GERONTOLOGY (2022)
Tendinopathy
Neal L. Millar et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Mapping the serum proteome to neurological diseases using whole genome sequencing
Grace Png et al.
NATURE COMMUNICATIONS (2021)
The CD33 short isoform is a gain-of-function variant that enhances Aβ1-42 phagocytosis in microglia
Abhishek Bhattacherjee et al.
MOLECULAR NEURODEGENERATION (2021)
Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression
Urmo Vosa et al.
NATURE GENETICS (2021)
Complex genetic signatures in immune cells underlie autoimmunity and inform therapy
Valeria Orru et al.
NATURE GENETICS (2020)
Overview of Mendelian Randomization Analysis
Young Ho Lee
JOURNAL OF RHEUMATIC DISEASES (2020)
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W. Kunkle et al.
NATURE GENETICS (2019)
CD33 in Alzheimer's Disease - Biology, Pathogenesis, and Therapeutics: A Mini-Review
Lingzhi Zhao
GERONTOLOGY (2019)
Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
Marie Verbanck et al.
NATURE GENETICS (2018)
The MR-Base platform supports systematic causal inference across the human phenome
Gibran Hemani et al.
ELIFE (2018)
Genomic atlas of the human plasma proteome
Benjamin B. Sun et al.
NATURE (2018)
Meta-analysis of the association between CD33 and Alzheimer's disease
Yu-Ting Jiang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
PhenoScanner: a database of human genotype-phenotype associations
James R. Staley et al.
BIOINFORMATICS (2016)
Alzheimer's Disease Risk Genes and Mechanisms of Disease Pathogenesis
Celeste M. Karch et al.
BIOLOGICAL PSYCHIATRY (2015)
Decreased expression of CD33 in peripheral mononuclear cells of Alzheimer's disease patients
Nan Hu et al.
NEUROSCIENCE LETTERS (2014)
CD33 Alzheimer's Risk-Altering Polymorphism, CD33 Expression, and Exon 2 Splicing
Manasi Malik et al.
JOURNAL OF NEUROSCIENCE (2013)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2013)
Alzheimer's Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
Ana Griciuc et al.
NEURON (2013)
Expression of Novel Alzheimer's Disease Risk Genes in Control and Alzheimer's Disease Brains
Celeste M. Karch et al.
PLOS ONE (2012)
Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants
Brandon L. Pierce et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2011)